BRÈVE publiée le 18/09/2026 à 17:30, il y a 1 mois 16 jours Funding Circle CFO Acquires Company Shares London Stock Exchange Ordinary Shares Share Purchase Funding Circle Tony Nicol
COMMUNIQUÉ DE PRESSE publié le 18/09/2026 à 17:25, il y a 1 mois 16 jours DSH-Director/PDMR Shareholding Funding Circle Holdings plc announces Chief Financial Officer's purchase of company shares. Details in accordance with EU Market Abuse Regulation Chief Financial Officer Market Abuse Regulation Funding Circle Company Shares Transaction Notification
BRÈVE publiée le 14/09/2026 à 16:05, il y a 1 mois 20 jours Funding Circle procède à un rachat d'actions à la Bourse de Londres Rachat D'actions Bourse De Londres Cercle De Financement Investec Actions Du Trésor
BRÈVE publiée le 14/09/2026 à 16:05, il y a 1 mois 20 jours Funding Circle Executes Share Buyback on LSE London Stock Exchange Share Buyback Treasury Shares Funding Circle Investec
COMMUNIQUÉ DE PRESSE publié le 14/09/2026 à 16:00, il y a 1 mois 20 jours Funding Circle Holdings plc: POS-Transaction in Own Shares Funding Circle Holdings plc purchased Ordinary Shares from Investec Bank plc as part of its buy-back. Company holds 8,869,082 shares in treasury Ordinary Shares Treasury Shares Funding Circle Holdings PLC Buy-back Investec Bank Plc
BRÈVE publiée le 07/09/2026 à 13:26, il y a 1 mois 27 jours Funding Circle procède à un rachat d'actions à la Bourse de Londres Rachat D'actions LSE Cercle De Financement Investec Actions Du Trésor
BRÈVE publiée le 07/09/2026 à 13:26, il y a 1 mois 27 jours Funding Circle Executes Share Buyback on LSE Share Buyback Treasury Shares LSE Funding Circle Investec
COMMUNIQUÉ DE PRESSE publié le 07/09/2026 à 13:21, il y a 1 mois 27 jours Funding Circle Holdings plc: POS-Transaction in Own Shares Funding Circle Holdings plc purchased Ordinary Shares from Investec Bank plc as part of its buy-back program. The Company now holds 8,488,251 Ordinary Shares in treasury Ordinary Shares Treasury Buy-back Program Funding Circle Holdings PLC Investec Bank Plc
BRÈVE publiée le 28/08/2026 à 17:53, il y a 2 mois 7 jours Annonce du nombre total de droits de vote par Funding Circle Holdings Capital Social Droits De Vote Totaux Règles De Transparence Avis Aux Actionnaires Cercle De Financement
BRÈVE publiée le 28/08/2026 à 17:53, il y a 2 mois 7 jours Total Voting Rights Announcement by Funding Circle Holdings Share Capital Total Voting Rights Transparency Rules Shareholder Notification Funding Circle
Publié le 04/11/2026 à 18:00, il y a 9 heures 27 minutes The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Publié le 04/11/2026 à 18:00, il y a 9 heures 27 minutes L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Publié le 04/11/2026 à 17:44, il y a 9 heures 43 minutes Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
Publié le 04/11/2026 à 23:10, il y a 4 heures 17 minutes Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Publié le 04/11/2026 à 23:00, il y a 4 heures 27 minutes Viemed Healthcare Announces Third Quarter 2026 Financial Results
Publié le 04/11/2026 à 22:15, il y a 5 heures 12 minutes Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Publié le 04/11/2026 à 22:05, il y a 5 heures 22 minutes Stabilis Solutions Announces Third Quarter 2026 Results
Publié le 05/11/2026 à 03:10, il y a 17 minutes SensAI Veritas Launches SensAI Gateway™ and SensAI Helm™: Bringing Risk Intelligence to the Moment of Trust
Publié le 05/11/2026 à 00:02, il y a 3 heures 25 minutes EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Publié le 04/11/2026 à 19:41, il y a 7 heures 46 minutes EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Publié le 04/11/2026 à 19:25, il y a 8 heures 2 minutes Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Publié le 04/11/2026 à 18:43, il y a 8 heures 44 minutes EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year
